Literature DB >> 18348518

New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues.

Ilse M Zolle1, Michael L Berger, Friedrich Hammerschmidt, Stefanie Hahner, Andreas Schirbel, Biljana Peric-Simov.   

Abstract

Derivatives of etomidate were evaluated as inhibitors of adrenal steroid 11beta-hydroxylations. Stereoselective coupling by Mitsunobu produced chirally pure analogues to study the effect of configuration, modification of the ester, and substitution in the phenyl ring, with the aim to probe specific sites for introducing a radionuclide. Iodophenyl metomidate (IMTO) labeled with iodine-131 served as radioligand for structure-affinity relationship studies. We have characterized the kinetic parameters of specific (131)I-IMTO binding on rat adrenal membranes and used the displacement of (131)I-IMTO binding to evaluate functionalized MTO analogues. Our results indicated that (1) ( R)-configuration is essential for high affinity, (2) highest potency resides in the ethyl, 2-propyl, and 2-fluoroethyl esters, and (3) substitution of the phenyl ring is well tolerated. The clinically used inhibitors metyrapone and ketoconazole inhibited (131)I-IMTO binding with low affinity. Incubation of selected analogues with human adrenocortical NCI-h295 cells demonstrated a high correlation with the inhibitory effect on cortisol secretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348518     DOI: 10.1021/jm800012w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function.

Authors:  Joseph F Cotten; Stuart A Forman; Joydev K Laha; Gregory D Cuny; S Shaukat Husain; Keith W Miller; Hieu H Nguyen; Elizabeth W Kelly; Deirdre Stewart; Aiping Liu; Douglas E Raines
Journal:  Anesthesiology       Date:  2010-03       Impact factor: 7.892

Review 2.  Clinical and molecular pharmacology of etomidate.

Authors:  Stuart A Forman
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

3.  Binding site location on GABAA receptors determines whether mixtures of intravenous general anaesthetics interact synergistically or additively in vivo.

Authors:  Daniel E Kent; Pavel Y Savechenkov; Karol S Bruzik; Keith W Miller
Journal:  Br J Pharmacol       Date:  2019-12-11       Impact factor: 8.739

4.  Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function.

Authors:  Joseph F Cotten; Ri Le Ge; Natalie Banacos; Ervin Pejo; S Shaukat Husain; James H Williams; Douglas E Raines
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

5.  First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases.

Authors:  Ulrike E Hille; Christina Zimmer; Carsten A Vock; Rolf W Hartmann
Journal:  ACS Med Chem Lett       Date:  2010-10-22       Impact factor: 4.345

6.  Optimization of the First Selective Steroid-11β-hydroxylase (CYP11B1) Inhibitors for the Treatment of Cortisol Dependent Diseases.

Authors:  Ulrike E Hille; Christina Zimmer; Jörg Haupenthal; Rolf W Hartmann
Journal:  ACS Med Chem Lett       Date:  2011-06-03       Impact factor: 4.345

7.  Cholesterol-derived glucocorticoids control early fate specification in embryonic stem cells.

Authors:  Joaquim Cabral-Teixeira; Almudena Martinez-Fernandez; Wenqing Cai; Andre Terzic; Mark Mercola; Erik Willems
Journal:  Stem Cell Res       Date:  2015-05-14       Impact factor: 2.020

8.  Analogues of etomidate: modifications around etomidate's chiral carbon and the impact on in vitro and in vivo pharmacology.

Authors:  Ervin Pejo; Peter Santer; Spencer Jeffrey; Hilary Gallin; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2014-08       Impact factor: 7.892

9.  Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.

Authors:  Joseph F Cotten; S Shaukat Husain; Stuart A Forman; Keith W Miller; Elizabeth W Kelly; Hieu H Nguyen; Douglas E Raines
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

10.  Sedative-hypnotic Binding to 11β-hydroxylase.

Authors:  Ervin Pejo; Xiaojuan Zhou; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.